Tirzepatide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP, aka: gastric inhibitory polypeptide) dual-receptor tract agonist, administered once a week.Both GLP-1 and GIP belong to the enteroglucagon, which is a polypeptide secreted by the mucous membranes of the gastrointestinal tract of the human body, and the former can bind with the receptor on the islet cells and GLP-1 and GIP are both enteroglucagon, peptides secreted by the mucosa of the human gastrointestinal tract. The former can bind to the receptors on pancreatic islet cells and stimulate insulin secretion to produce glucose-lowering effects, as well as delaying gastric emptying and suppressing appetite, thus controlling body weight; the latter has the ability to inhibit the secretion of gastric acid, pepsin, stimulate insulin release, and inhibit gastric peristalsis and emptying, which complements the effects of the GLP-1 agonist. diabetes mellitus and represents a novel class of drugs for the treatment of type 2 diabetes mellitus.
 |
 |
 |
 |
 |
 |
Market Demand Viewpoints
Growing Demand for Weight Loss:
With changing lifestyles, obesity and overweight problems are becoming increasingly prevalent in Poland and other European countries, and the market demand for weight loss drugs is growing. According to data forecasts, the market size of GLP-1 weight loss drugs will expand rapidly in the next few years, which provides a broad prospect for the sales of Tirzepatide in the Polish market.
Demand for treatment of obesity-related diseases:
Obesity is associated with a variety of diseases, such as diabetes, cardiovascular diseases, respiratory diseases, etc. Tirzepatide, as a weight-loss and diabetes treatment drug, can improve metabolic indexes while controlling body weight, which is potentially valuable for the treatment of these diseases. In Poland, there is a large number of patients suffering from obesity-related diseases and the demand for Tirzepatide has increased.
High interest in new weight loss drugs:
Polish customers are highly interested in new weight loss drugs and are willing to try innovative treatment options.Tirzepatide, as an emerging weight loss drug, attracts their attention with its unique mechanism of action and favorable efficacy, prompting them to choose to purchase it.
Product Characteristics
Significant weight loss effect:
Tirzepatide can activate both GLP-1 receptor and GIP receptor. Activation of GLP-1 receptor delays gastric emptying and suppresses appetite, while activation of GIP receptor promotes insulin secretion and reduces food intake, resulting in significant weight loss effect. Clinical trial data show that obese patients treated with Tirzepatide can lose a significant amount of weight, which meets the expectations of Polish customers for weight loss results.
Good metabolic improvement effect:
In addition to its weight loss effect, Tirzepatide also improves metabolic indicators such as blood glucose, blood lipids and blood pressure, and reduces the risk of cardiovascular disease. This combined metabolic improvement effect is highly attractive for obese patients among Polish customers concerned about their overall health.
Relatively good safety profile:
Tirzepatide has demonstrated a relatively good safety profile in clinical trials, with most common adverse effects being mild to moderate and occurring early in the course of the drug's administration, and then diminishing or disappearing over time. This makes Polish customers prefer Tirzepatide when choosing a weight loss medication, as it does not cause serious negative effects on the body while losing weight.
Brand and Market
BLOOM TECH'S BRAND INFLUENCE
Tirzepatide is a weight loss and diabetes treatment drug developed by BLOOM TECH and its partner factories. After many order transactions and cooperation, Polish customers have higher trust in BloomTech's brand, and therefore are more willing to choose its Tirzepatide products.
BLOOM TECH'S MARKETING
BLOOM TECH promotes Tirzepatide in the Polish market through Google promotion and improving the professionalism of its sales staff to enhance the conversion rate of inquiries in order to increase product awareness and recognition. The advantages of Tirzepatide may also be communicated to Polish customers through the organization of health seminars and online promotions to stimulate their desire to purchase the product.
Advantage of price and cost-effectiveness:
BLOOM TECH's Tirzepatide products may be competitively priced or have high cost-effectiveness in terms of therapeutic efficacy and safety, which makes Polish customers think that purchasing the product is an affordable option.